IL-6 Stabilizes Twist and Enhances Tumor Cell Motility in Head and Neck Cancer Cells through Activation of Casein Kinase 2
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-6 Stabilizes Twist and Enhances Tumor Cell Motility in Head and Neck Cancer Cells through Activation of Casein Kinase 2
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 4, Pages e19412
Publisher
Public Library of Science (PLoS)
Online
2011-04-30
DOI
10.1371/journal.pone.0019412
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emergence of protein kinase CK2 as a key target in cancer therapy
- (2010) Janeen H. Trembley et al. BIOFACTORS
- CK2 Modulation of NF- B, TP53, and the Malignant Phenotype in Head and Neck Cancer by Anti-CK2 Oligonucleotides In vitro or In vivo via Sub-50-nm Nanocapsules
- (2010) M. S. Brown et al. CLINICAL CANCER RESEARCH
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion
- (2010) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage
- (2010) A Vichalkovski et al. ONCOGENE
- Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck
- (2010) Schultz ONCOLOGY REPORTS
- Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies
- (2009) Ana M Solares et al. BMC CANCER
- Characterization of sequences in human TWIST required for nuclear localization
- (2009) Shalini Singh et al. BMC CELL BIOLOGY
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- Protein Kinase CK2 in Health and Disease
- (2009) N. A. St-Denis et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma
- (2009) S. Shinriki et al. CLINICAL CANCER RESEARCH
- EGF-Induced ERK Activation Promotes CK2-Mediated Disassociation of α-Catenin from β-Catenin and Transactivation of β-Catenin
- (2009) Haitao Ji et al. MOLECULAR CELL
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
- (2009) N J Sullivan et al. ONCOGENE
- The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers
- (2009) Hervé Wallerand et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas
- (2008) M Colomiere et al. BRITISH JOURNAL OF CANCER
- Interleukin-6 predicts recurrence and survival among head and neck cancer patients
- (2008) Sonia A. Duffy et al. CANCER
- Twist Is Transcriptionally Induced by Activation of STAT3 and Mediates STAT3 Oncogenic Function
- (2008) George Z. Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor
- (2008) P. P. Scaglioni et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Direct regulation of TWIST by HIF-1α promotes metastasis
- (2008) Muh-Hwa Yang et al. NATURE CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now